FIGURE

Figure 10

ID

ZDB-FIG-221226-289

Publication

Ruzic et al., 2022 - Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation

Other Figures

All Figure Page

Back to All Figure Page

Figure 10

Anti-cancer and anti-metastatic activity of a new HDAC inhibitor 8b against highly metastatic human breast carcinoma MDA-MB-231 cells in zebrafish xenografts. Tg(fli1:EGFP) xenografts (n = 20) were exposed to three different doses of 8b, and analyzed for tumor progression and metastasis after 3-day treatment. Representative fluorescent microscopy images are shown (A); white arrows indicate disseminated cells. The applied treatments markedly reduced the MDA-MB-231 tumor growth (B), number of embryos with metastasis (C), as well as the number of disseminated cancer cells per xenograft (D), as compared to those in the control group (p < 0.001, for all hallmarks). Data are normalized in relation to the control group ((B–D) *** p < 0.001).

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Pharmaceutics